Ortho Dermatologics Announces 2018 Aspire Higher Scholarship Recipients

Scholarships Awarded to Nine Students Affected by Dermatologic Conditions

LAVAL, Quebec, Aug. 8, 2018 /CNW/ -- Ortho Dermatologics, one of the largest prescription dermatology health care businesses in the world and a division of Bausch Health Companies Inc. (NYSE/TSX: BHC), today announced the 2018 honorees of the Aspire Higher program, which since 2013 has granted more than $450,000 in scholarships to students who have been affected by dermatologic conditions. This year nine students will receive scholarships of $10,000 each to pursue graduate or undergraduate degrees at an accredited, nonprofit, two- or four-year college, university, or advanced (post-high school) vocational or technical school.

(PRNewsfoto/Valeant Pharmaceuticals Interna)

"At Ortho Dermatologics, we understand that there is more to skin conditions than what meets the eye, and managing them often comes with challenges. We're proud to continue the Aspire Higher program to help students who have faced such challenges reach their educational goals, while also recognizing the positive impact dermatologists have had on their lives," said Bill Humphries, president, Ortho Dermatologics.

The 2018 honorees were selected from nearly 1,200 applications, based in part on essays sharing their experience of living with a dermatologic condition, as well as the role that a dermatologist, physician assistant or nurse practitioner has played in helping treat it. The applications were judged by an independent panel of dermatologists from across the country.

"In the six years that I have served on the judging panel for the Aspire Higher program, I continue to be inspired by these students' dedication to education and passion to excel in their future careers," said Jonathan S. Weiss, M.D., dermatologist at Gwinnett Dermatology, Snellville, GA. "This is one of the most outstanding initiatives taking place in the dermatology community, and I am proud to join Ortho Dermatologics to help these outstanding students achieve their educational dreams and continue aspiring higher."

The Aspire Higher program recognizes students at varying stages of their educational careers through scholarships in three categories, including the Undergraduate Scholar Awards for those pursuing undergraduate degrees, the Graduate Scholar Awards for those pursuing graduate degrees, and the Today's Woman Scholar Awards for mothers pursuing undergraduate or graduate degrees.

The 2018 Aspire Higher recipients include:

• Undergraduate Scholar Award
• Jayla Chanel Davis, Alabaster, AL – University of South Alabama
• Daisy Pena, San Jose, CA – California State University Long Beach
• Mary Margaret Jordan, Melissa, TX – Baylor University
  
• Graduate Scholar Award
• Zoe Smith, Ferndale, MI – Wayne State School of Medicine
• Niki Vora, Buena Park, CA – UC Berkeley - UCSF Joint Medical Program
• Caitlin Parker, Taylorsville, UT – Roseman University of Health Sciences - College of Dental Medicine
  
• Today's Woman Scholar Award
• Laura Lukens, Evanston, IL – Northwestern University - Kellogg School of Management
• Elizabeth Hendrix, Holladay, UT – University of Utah
• Jennifer Hurley, Hammonton, NJ – Fairleigh Dickinson University

"With the generous help of Ortho Dermatologics and the Aspire Higher scholarship program, I'm thrilled to continue my education at California State University Long Beach," said Daisy Pena. "It is wonderful that this program exists to help those who have struggled with their skin accomplish their academic goals – and I look forward to taking full advantage of this incredible opportunity while also raising awareness of skin conditions like alopecia."

To learn more about the Aspire Higher scholarship, please visit www.AspireHigherScholarships.com. The 2019 Aspire Higher scholarship program will begin accepting applications in early 2019.

About Aspire Higher and Other Ortho Dermatologics' Philanthropic Initiatives
Since 2013, the Aspire Higher scholarship program has awarded 32 scholarships, which gave students a total of more than $450,000 toward their higher education on campuses nationwide. Ortho Dermatologics also matches donations to help children with chronic skin conditions enjoy a week of fun and adventure at the American Academy of Dermatology's Camp Discovery. The Aspire Higher Scholarship program is funded through the Bausch Foundation, which was established in 2017 to improve the lives of patients globally by providing access to safe, effective medicines and by financially supporting health care education and causes around the world.

About Ortho Dermatologics
Ortho Dermatologics, a Bausch Health company, is one of the largest prescription dermatology businesses in the world dedicated to helping patients in the treatment of a range of therapeutic areas including actinic keratosis, acne, atopic dermatitis, cold sores, athlete's foot, nail fungus and other dermatoses. The Ortho Dermatologics portfolio includes several leading acne, antifungal and anti-infective products. More information can be found at www.ortho-dermatologics.com.

About Bausch Health 
Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. More information can be found at www.bauschhealth.com.

Forward-looking Statements 
This news release may contain forward-looking statements, which may generally be identified by the use of the words "anticipates," "expects," "intends," "plans," "should," "could," "would," "may," "will," "believes," "estimates," "potential," "target," or "continue" and variations or similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to, risks and uncertainties discussed in the Company's most recent annual or quarterly report and detailed from time to time in the Company's other filings with the Securities and Exchange Commission and the Canadian Securities Administrators, which factors are incorporated herein by reference. In addition, certain material factors and assumptions have been applied in making these forward-looking statements, including that the risks and uncertainties outlined above will not cause actual results or events to differ materially from those described in these forward-looking statements. The Company believes that the material factors and assumptions reflected in these forward-looking statements are reasonable, but readers are cautioned not to place undue reliance on any of these forward-looking statements. These forward-looking statements speak only as of the date hereof. Bausch Health undertakes no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this news release or to reflect actual outcomes, unless required by law.

All product/brand names and/or logos are trademarks of the respective owners.

Copyright © 2018 All Rights Reserved.

NPR.0411.USA.18

 

 

SOURCE Bausch Health Companies Inc.

Related Links

https://www.bauschhealth.com